2024-04-26 15:38:53
The Quirónsalud Group has launched the HOPE project (Personalized Day Hospital), an innovative care initiative for cancer patients that has reduced the time these patients spend in the day hospital by 80%.
The managing director of the Quirónsalud Málaga Hospital, Dr. Tomás Urda (3d), accompanied by the national president of the Spanish Association Against Cancer (AECC), Dr. Ramón Reyes (i); the president of the Andalusian Society of Medical Oncology, Dr. Ana Laura Ortega; the president of the Spanish Society of Radiation Oncology (SEOR), Dr. Mª Carmen Rubio; and Manuel Cobo and Jorge Contreras (d), specialists from the Oncology Service of the Quirónsalud Málaga Hospital, take part in the discussion table “Future in the management of cancer patients” during the II National Multidisciplinary Conference on Innovation in Cancer, today Friday in Malaga. EFE/Jorge Zapata
Implemented in a pioneering way at the Jiménez Díaz Foundation in Madrid, HOPE will soon arrive at the Quirónsalud Málaga Hospital, as announced this Friday by Dr. Cristina Caramés, Medical and Research Director of this hospital group, during the ‘II National Multidisciplinary Conference on Innovation in Cancer’, which has brought together a hundred experts in this field.
HOPE restructures the care process for cancer patients, trying to ensure that the approach to this disease affects their routine and life as little as possible, avoiding travel and reducing waiting times.
“It all arises when we analyze that in the classic process there were many steps that did not add any value, such as waiting or travel, so we redesigned the model to be the health professionals and the hospital who are going to be around the patient and their family and not the other way around,” explained Dr. Caramés.
Thus, “by improving the process and putting the patient at the center”, added the oncologist, it has been possible to reduce the time in the day hospital for these patients by 80%.
Similarly, hospital admissions due to serious toxicity of the treatment have decreased by up to 38%, unnecessary appointments between cycles by 62%, the average time to receive a treatment has gone from between 9 and 13 hours to 2 or 3 and the The administrative burden of the oncologist has decreased by 98%, Caramés pointed out.
The scientific journal ‘New England Journal of Medicine’ has published the results of this project, which will be progressively implemented in all the group’s hospitals. “We are going to provide all the tools to facilitate the process,” said the doctor.
More clinical research
The conference, organized by the Comprehensive Oncology Unit of the Quirónsalud Málaga Hospital, addressed the latest advances in the treatment of cancer, a disease that causes the death of almost 10 million people around the world each year, 160,000 of them. in Spain, where the number of cancers diagnosed in 2024 is expected to exceed 286,000.
Given these data, experts have agreed to highlight that the future lies in research in oncology, which is why they have asked to “make an effort” in this field to reduce the incidence of the disease.
In this sense, Dr. Manuel Cobo, coordinating oncologist, together with Dr. Cristina Quero, from the Oncology Research Unit of the Quirónsalud Málaga Hospital, has indicated that this center has already committed more than 20 clinical trials for the use of new drugs. .
These clinical trials “provide the opportunity to access cutting-edge treatments that could significantly improve outcomes for cancer patients, and even provide treatment opportunities when there are no other alternatives,” stressed Dr. Jorge Contreras, head of the Comprehensive Treatment Service. Oncology at the Quirónsalud Málaga Hospital.
Contreras recalled that “incidence and mortality are increasing due to an increasingly older population”, but that the trend is more towards the chronicification of the disease thanks to the latest advances in treatment.
The patient at the center of everything
In addition to the use of new drugs and molecular targets, the latest in cancer treatment involves minimally invasive surgeryadvanced chemotherapy and radiotherapy combined with hyperthermia and the use of new drugs and molecular targets.
New techniques such as the so-called uniportal surgery, which Dr. Roberto Mongil, head of the Thoracic Surgery Service at Quirónsalud Málaga, has spoken about, who is a pioneer in Andalusia in the use of this methodology, which involves the removal of the tumor through a single incision. of 2-3 centimeters in the absence of rib separation, which allows an earlier recovery of patients, a lower rate of complications and less postoperative pain.
For his part, Dr. César Ramírez, head of the General and Digestive Surgery Service at Quirónsalud Málaga, has explained the benefits of minimally invasive surgery with intraperitonial chemotherapy and hyperthermia, a technique in which the Quirónsalud Hospital is a national reference.
Other experts participated in the meeting, such as the president of the Spanish Association Against Cancer (AECC), Dr. Ramón Reyes; the president of the Spanish Society of Radiation Oncology (SEOR), Dr. María Carmen Rubio; the president of the Andalusian Society of Medical Oncology, Dr. Ana Laura Ortega, and the managing director of the Quirónsalud Hospital MálagaDr. Tomás Urda.
They shared a round table in which they talked about the present and future in the management of cancer patients and the importance of personalizing treatment and humanizing the process.
The managing director of the Quirónsalud Málaga Hospital, Dr. Tomás Urda (i), accompanied by Manuel Cobo (d), specialists from the Oncology Service of the Quirónsalud Málaga Hospital, participates in the discussion panel “Future in the management of cancer patients” during the II National Multidisciplinary Conference on Cancer Innovation, today Friday in Malaga. EFE/Jorge Zapata
#Hope #reduces #cancer #patients #time #hospital